Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
| Status: | Completed |
|---|---|
| Conditions: | Depression, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 3/1/2014 |
| Start Date: | January 2010 |
| End Date: | December 2014 |
| Contact: | Brian Martens, MS |
| Email: | brian.martens@lindnercenter.org |
| Phone: | 513-536-0720 |
Adjunctive Lisdexamfetamine in Bipolar Depression
The specific aim of this study is to evaluate the efficacy and tolerability of
lisdexamfetamine in the adjunctive treatment of bipolar disorder.
lisdexamfetamine in the adjunctive treatment of bipolar disorder.
Inclusion Criteria:
- Subjects will meet DSM-IV-TR criteria bipolar I or II disorder,
Exclusion Criteria:
- Women who are pregnant, lactating, or of childbearing potential who are not using
adequate contraceptive measures.
- Clinically unstable medical disease, including cardiovascular, hepatic, renal,
gastrointestinal, pulmonary, metabolic, endocrine or other systemic disease.
Subjects should be biochemically euthyroid to enter the study.
We found this trial at
1
site
